Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Sirona Biochem Corp > “Skin in the game” yeah right.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1167)
•••
Comment by Pandoraon Feb 07, 2023 12:18pm
99 Views
Post# 35272037

RE:“Skin in the game” yeah right.

RE:“Skin in the game” yeah right.
Pareto8020 wrote: I love how on the SBM website they promote how many shares Howie, Chris and Geraldine have of SBM and that their interests align with shareholders.

 I'd be interested in seeing how many of those were bought on the open market vs. gifted to themselves in the form of options, bonuses, etc.  Geraldine deserves everything she has - the other 2 have led the company down the wrong path repeatedly and shouldn't even be allowed to be pulling a salary never mind all the shares they've granted to themselves for a job NOT well done.

Howard - LEAVE SBM YOU ARE INCOMPETENT AND  HAVE DONE WAY MORE HARM THAN GOOD!  Prove me wrong - double dog dare you.


Have you looked at what the severance package is?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities